Paper · 28624924
Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.
Horowitz JM and 12 others. Abdom Radiol (NY), 2017. Cited by 117 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Papers, record 28624924. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28624924
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis | Major topic |
| Contrast Media | |
| Early Diagnosis | |
| Humans | |
| Image Interpretation, Computer-Assisted |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 EB020710 | NIBIB NIH HHS | United States | K23EB020710 | PubMed and NIH | NIH RePORTER |
| R37 EB001981 | NIBIB NIH HHS | United States | R37EB001981 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References187
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,484,010 | Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. | Am J Gastroenterol | 1999 | https://conductscience.org/library/papers/10484010 | PubMed |
| 2 | 21,768,237 | Dual-energy (spectral) CT: applications in abdominal imaging. | Radiographics | 2011 | https://conductscience.org/library/papers/21768237 | PubMed |
| 3 | 15,115,333 | Liver fibrosis: from the bench to clinical targets. | Dig Liver Dis | 2004 | https://conductscience.org/library/papers/15115333 | PubMed |
| 4 | 20,529,989 | Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. | Radiology | 2010 | https://conductscience.org/library/papers/20529989 | PubMed |
| 5 | 10,341,686 | The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. | Br J Radiol | 1999 | https://conductscience.org/library/papers/10341686 | PubMed |
| 6 | 22,836,161 | Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. | Eur Radiol | 2013 | https://conductscience.org/library/papers/22836161 | PubMed |
| 7 | 26,612,465 | Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis. | Sci Rep | 2015 | https://conductscience.org/library/papers/26612465 | PubMed |
| 8 | 26,032,126 | MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. | Eur J Radiol | 2015 | https://conductscience.org/library/papers/26032126 | PubMed |
| 9 | 27,190,762 | T2 relaxation time is related to liver fibrosis severity. | Quant Imaging Med Surg | 2016 | https://conductscience.org/library/papers/27190762 | PubMed |
| 10 | 27,527,587 | Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats. | J Magn Reson Imaging | 2017 | https://conductscience.org/library/papers/27527587 | PubMed |
1 to 10 of 187
See all 187 referencesCited by72
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,934,385 | Adaptive Liver Stiffness Quantification in Magnetic Resonance Elastography Using a Heterogeneity-Aware Deep Learning Framework. | J Imaging Inform Med | 2026 | https://conductscience.org/library/papers/42934385 | PubMed |
| 42,911,394 | Dual-layer spectral CT-derived iodine and extracellular volume biomarkers for noninvasive assessment of hepatic fibrosis in Fontan-associated liver disease. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/42911394 | PubMed |
| 42,519,788 | Imaging-based fibrosis assessment and risk stratification in MASLD. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42519788 | PubMed |
| 41,884,131 | Risk score to predict fibrosis among Mexican adults: results of the Health Workers Cohort Study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41884131 | PubMed |
| 41,601,755 | Non-invasive assessment of liver fibrosis staging in chronic hepatitis B patients: combining two-dimensional shear wave elastography with serum indicators. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41601755 | PubMed |
| 41,301,814 | Effect of Hepatitis C Virus Genotype, Cirrhosis, and Viral Cure on Serum Phosphatidylinositol Species Profiles. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301814 | PubMed |
| 41,121,515 | Quantitative Assessment of Liver Fibrosis: B1 Inhomogeneity-Corrected VFA T1 Mapping on Gadobenate Dimeglumine-Enhanced MRI. | Curr Med Imaging | 2025 | https://conductscience.org/library/papers/41121515 | PubMed |
| 41,006,805 | The pathogenesis of liver fibrosis in Wilson's disease: hepatocyte injury and regulation mediated by copper metabolism dysregulation. | Biometals | 2026 | https://conductscience.org/library/papers/41006805 | PubMed |
| 40,932,487 | Multi-institutional survey on abdominopelvic applications of MR elastography. | Eur Radiol | 2026 | https://conductscience.org/library/papers/40932487 | PubMed |
| 40,893,541 | Deep learning-based automated assessment of hepatic fibrosis via magnetic resonance images and nonimage data. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/40893541 | PubMed |
1 to 10 of 72
See all 72 cited byGenes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| A2M | 2 | PubTator's text mining | https://conductscience.org/library/genes/2 | NCBI Gene |
| GGT1 | 2,678 | PubTator's text mining | https://conductscience.org/library/genes/2678 | NCBI Gene |
| HP | 3,240 | PubTator's text mining | https://conductscience.org/library/genes/3240 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28624924
GET https://conductscience.org/api/papers/v1/28624924/references?page=2